Clinical Trial Update: Clinical Benefit, Safety, PK and PD Study of AT-007 in Pediatric Subjects With Classic Galactosemia [Phase 2, Phase 3]

View source ↗

Summary

This document reports the results of a Phase 2/3 clinical trial evaluating AT-007 in pediatric patients with Classic Galactosemia, focusing on clinical benefit,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Classic Galactosemia

Drugs mentioned

• AT 007

Snippet

Sponsor: Applied Therapeutics, Inc. | Conditions: Classic Galactosemia | Phase 2, Phase 3 | Status: COMPLETED